AzTrials
AzTrials

Type 1 Diabetes4301NCT00491465

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

A study testing Intensive Physical activity in people with Type 1 Diabetes, run by Rabin Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. Read more about this study

Who is it for?
Ages 8 to 16 years
Conditions the study is for
Type 1 Diabetes
What is being tested?
Intensive Physical activity
How many people
2,007 participants
Where
1 siteIsrael
Study dates
Jul 2007to Jul 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Type I diabetic children
  • Tanner stage II-IV
  • Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
  • more than one year.
  • HbA1C between 8 and 12 at time 0.
  • Mandatory 4 daily self blood glucose measurements and daily recording of adverse events.
  • A signed informed consent of the parents and child.

Who cannot join

  • Additional chronic significant disease such as cardiac, liver, renal disease .
  • Children who exercise regularly more than 180 min per week.
  • Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
  • Eating disorders.
  • Participation in a study during the past month.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Schnider children's medical center

    Petah Tikva

    Ravital Nimri, MD

    Moshe Phillip, Prof.

Other trials in Israel

About this study

Official title: Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.

Read the detailed description

Randomized, controlled, open, comparative, cross-over, intervention study in 50 children with type 1 diabetes.

objectives:

Primary objective To evaluate the efficacy and safety of physical activity for metabolic control in children with type I diabetes.

Secondary objectives

  1. To characterize the severity and pattern of occurrence of hypo and hyperglycemic episodes during and after exercise program in type I diabetic children.
  2. To evaluate changes in insulin sensitivity during and after periods of exercise in type I diabetic children.
  3. To evaluate the short term effect of exercise on BMI and body composition in type I diabetic children.
  4. To evaluate the short term effect of exercise on lipid profile in type I diabetic children.
  5. To evaluate differences in self esteem and quality of life between exercising and non exercising type I diabetic children.

Randomization:

Children will be randomly allocated into two groups of 25.The study will be conducted in a crossover manner:one group starting with the intensive arm followed by the non intensive arm and vice versa.

methods:

  1. The study will have an intensive arm and a non intensive arm, each lasting 12 weeks.
  2. Children fulfilling the inclusion and exclusion criteria will be randomly assigned to two groups. Each group will include 25 patients.
  3. Participants will fill questionnaires regarding physical activity.
  4. The first group will start with the intensive arm, followed by one month washout, and then the non intensive arm.
  5. The second group will start the study with the non intensive arm, followed by one month washout and then the intensive arm .
  6. The intensive arm will consist of an exercise program which will include high intensity progressive exercise (75% maximum age adjusted heart rate HRmax) 3 days a week for 90 minutes. The 90 min exercise will be a combination of aerobic exercise 45min. and resistance exercise 45 min.
  7. The exercise program will be planned and carried out by professional sports instructors.
  8. During the non intensive arm the participants will resume regular daily activity. They will keep records of their weekly physical activity and will get a weekly phone call from the treating doctor, addressing specifically physical activity performed during the past week and glucose levels before and after exercise.
  9. The following parameters will be measured for both groups at the beginning and the end of the intensive and non intensive arm and once again 12 weeks afterwards : Weight, height, pulse, blood pressure, waist circumference, skin folds, HbA1C , fructosamine ,3 days CGMS +3 day SBGM profile (will be measured to 40% of participants chosen randomly) ,total daily insulin dose ,blood sample for fasting lipid profile ,Body impedance and BMR , self esteem and quality of life questionnaires .
  10. Study participants will be required to measure blood glucose by glucometer at least 4 times a day and to record hypo and hyperglycemic events and their severity.

15.Both children and investigators will be blinded to CGMS results. 16.During the 3 day CGMS recording, the children's parents will be asked to monitor SBGM once during the night (in the intensive arm, following the exercise day).

Conditions
Type 1 Diabetes
Being tested
Intensive Physical activity, Control- regular physical activity
Keywords
Type 1 Diabetes, physical activity, pediatric, metabolic control
Medical subject headings
Diabetes Mellitus, Type 1, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive Physical activityBehavioural

  • Control- regular physical activityBehavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HbA1C

    Measured: 0,3 monthes

  2. fructosamine

    Measured: 0,3 monthes

Secondary outcomes (3)
  1. Body composition & BMR

    Measured: 0,3 monthes

  2. Self esteem & QOL questionnaires

    Measured: o, 3 monthes

  3. 3 days CGMS & SBGM profile

    Measured: 0,3 monthes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2007 (estimated)
  2. Study startJul 2007
  3. Study completionJul 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
2,007 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00491465
Sponsor's protocol ID
rmc074301ctil
Acronym
4301
Status last verified
Jun 2007
First submitted
25 Jun 2007
Last updated
26 Jun 2007
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Intensive Physical activity in people with Type 1 Diabetes, run by Rabin Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jun 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ravital Nimri, MD (972-39253778 ext. direct, ravitaln@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HbA1C (time frame: 0,3 monthes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in